神經內視鏡市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球神經內視鏡市場價值為 1.585 億美元，預計在 2025 年至 2034 年期間的複合年成長率為 5.7%，這得益於腦腫瘤發病率的上升以及對微創神經外科手術的偏好日益增加。隨著全球神經系統疾病負擔不斷增加，神經內視鏡檢查正成為關鍵的解決方案，為治療各種腦部疾病提供更精確、侵入性更小的選擇。隨著影像和內視鏡技術的進步，神經內視鏡技術使外科醫生能夠以更好的可視化和準確性導航複雜的腦結構，從而減少患者的創傷，縮短恢復期，並改善手術效果。

對神經系統疾病（包括神經膠質瘤和腦下垂體腺瘤）的早期診斷和有效治療的需求不斷成長，進一步擴大了對先進神經內視鏡設備的需求。此外，人口老化更容易患神經系統疾病，這也推動了市場需求，而內視鏡工具和配件的不斷創新有助於擴大全球神經內視鏡手術的範圍。醫療機構擴大投資於整合高清光學和機器人輔助的尖端設備，使神經外科醫生能夠以更高的安全性和效率執行複雜的手術。

市場分為硬性神經內視鏡和軟性神經內視鏡，其中硬性神經內視鏡佔據最大佔有率的收入。 2024 年，硬質神經內視鏡市場收入達到 1.041 億美元，反映了其在複雜神經外科手術中的廣泛應用。硬質神經內視鏡因其在腫瘤切除術、腦室造口術和腦室內手術等手術過程中出色的可視化能力和穩定性而受到青睞。其堅固的設計和高精度使其成為解決手術準確性至關重要的複雜神經系統病例的必需品。隨著越來越多的醫療保健提供者專注於以最少的併發症實現更好的患者治療效果，硬性神經內視鏡的採用率持續上升。

神經內視鏡也根據可用性分為可重複使用和一次性類型，其中可重複使用的神經內視鏡在 2024 年產生 1.372 億美元的收入。這些設備因其成本效益和耐用性而越來越受到青睞，尤其是在高容量手術中心。可重複使用的神經內視鏡可顯著降低長期營運成本，並透過最大限度地減少醫療廢物，滿足醫療保健行業日益重視的永續性。醫院和專科診所正在採用可重複使用的設備來平衡臨床表現和環境責任，使其成為全球機構的首選。

從區域來看，美國神經內視鏡市場在 2024 年達到 5,610 萬美元，預計 2025 年至 2034 年的複合年成長率為 4.8%。神經系統疾病盛行率的上升，加上對微創干預的需求，正在推動美國市場的成長。機器人輔助神經內視鏡和先進影像解決方案（如 4K 超高清視覺化系統）的日益融合有望徹底改變神經外科實踐，提高精確度和病患治療效果。隨著美國醫療保健提供者不斷擁抱技術進步，預計未來十年對神經內視鏡設備的需求將出現強勁成長。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 腦瘤病例不斷增加
    • 微創外科手術需求激增
    • 神經外科的技術進步
    • 老年人口不斷增加
  • 產業陷阱與挑戰
    • 設備和手術費用高昂
• 成長潛力分析
• 監管格局
• 技術格局
• 報銷場景
• 差距分析
• 波特的分析
• PESTEL分析
• 未來市場趨勢

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按產品，2021 - 2034 年

• 主要趨勢
• 硬質神經內視鏡
  • 硬質纖維鏡
  • 硬式視訊內視鏡
• 軟性神經內視鏡

第6章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 經鼻神經內視鏡檢查
• 腦室內神經內視鏡檢查
• 經顱神經內視鏡檢查

第7章：市場估計與預測：按可用性，2021 - 2034 年

• 主要趨勢
• 可重複使用的神經內視鏡
• 免洗神經內視鏡

第 8 章：市場估計與預測：按患者，2021 年至 2034 年

• 主要趨勢
• 成人
• 兒科

第9章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 診斷中心
• 其他最終用途

第10章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：公司簡介

• Ackermann
• adeor MEDICAL
• ADVANCED BIOLOGICS
• Advin Health care
• B. Braun
• Chongqing Xishan Science & Technology
• CLARUS MEDICAL
• joimax
• KARL STORZ
• Machida
• SCHINDLER ENDOSKOPIE TECHNOLOGIE

The Global Neuroendoscopy Market was valued at USD 158.5 million in 2024 and is poised to grow at a CAGR of 5.7% between 2025 and 2034, driven by the increasing incidence of brain tumors and the rising preference for minimally invasive neurosurgical procedures. As the global burden of neurological disorders continues to surge, neuroendoscopy is emerging as a critical solution, offering more precise and less invasive options for treating a variety of brain conditions. With advancements in imaging and endoscopic technology, neuroendoscopy allows surgeons to navigate complex brain structures with improved visualization and accuracy, resulting in reduced patient trauma, shorter recovery periods, and better surgical outcomes.

The growing demand for early diagnosis and effective treatment of neurological diseases, including gliomas and pituitary adenomas, is further amplifying the need for advanced neuroendoscopic devices. Additionally, an aging population, which is more prone to neurological conditions, is driving market demand, while ongoing innovations in endoscopic tools and accessories are helping to broaden the scope of neuroendoscopic procedures worldwide. Healthcare facilities are increasingly investing in cutting-edge devices that integrate high-definition optics and robotic assistance, enabling neurosurgeons to perform intricate surgeries with enhanced safety and efficiency.

The market is segmented into rigid and flexible neuroendoscopes, with rigid neuroendoscopes holding the largest share of the revenue. In 2024, the rigid neuroendoscope segment generated USD 104.1 million, reflecting their widespread use in complex neurosurgical procedures. Rigid neuroendoscopes are preferred for their superior visualization capabilities and stability during surgeries such as tumor resections, ventriculostomies, and intraventricular procedures. Their robust design and high precision make them essential for addressing challenging neurological cases where surgical accuracy is paramount. As more healthcare providers focus on achieving better patient outcomes with minimal complications, the adoption of rigid neuroendoscopes continues to rise.

Neuroendoscopes are also classified based on usability into reusable and disposable types, with reusable neuroendoscopes generating USD 137.2 million in 2024. These devices are increasingly favored for their cost-efficiency and durability, especially in high-volume surgical centers. Reusable neuroendoscopes significantly reduce operational costs over time and align with the growing emphasis on sustainability within the healthcare sector by minimizing medical waste. Hospitals and specialty clinics are adopting reusable devices to balance clinical performance with environmental responsibility, making them a top choice for institutions worldwide.

In regional terms, the U.S. Neuroendoscopy Market reached USD 56.1 million in 2024 and is projected to expand at a CAGR of 4.8% from 2025 to 2034. The rising prevalence of neurological disorders, coupled with the demand for minimally invasive interventions, is propelling market growth in the U.S. The increasing integration of robotic-assisted neuroendoscopy and advanced imaging solutions, such as 4K ultra-high-definition visualization systems, is expected to revolutionize neurosurgical practices, improving precision and patient outcomes. As U.S. healthcare providers continue to embrace technological advancements, the demand for neuroendoscopic devices is anticipated to witness robust growth over the next decade.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of brain tumor cases
    • 3.2.1.2 Surging demand for minimally invasive surgical procedures
    • 3.2.1.3 Technological advancements in neurosurgery
    • 3.2.1.4 Growing elderly population
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with devices and surgeries
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Reimbursement scenario
• 3.7 Gap analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 Future market trends

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Rigid neuroendoscopes
  • 5.2.1 Rigid fiberscopes
  • 5.2.2 Rigid videoscopes
• 5.3 Flexible neuroendoscopes

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Transnasal neuroendoscopy
• 6.3 Intraventricular neuroendoscopy
• 6.4 Transcranial neuroendoscopy

Chapter 7 Market Estimates and Forecast, By Usability, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Reusable neuroendoscopes
• 7.3 Disposable neuroendoscopes

Chapter 8 Market Estimates and Forecast, By Patient, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Adult
• 8.3 Pediatric

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Ambulatory surgical centers
• 9.4 Diagnostic centers
• 9.5 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 Middle East and Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Ackermann
• 11.2 adeor MEDICAL
• 11.3 ADVANCED BIOLOGICS
• 11.4 Advin Health care
• 11.5 B. Braun
• 11.6 Chongqing Xishan Science & Technology
• 11.7 CLARUS MEDICAL
• 11.8 joimax
• 11.9 KARL STORZ
• 11.10 Machida
• 11.11 SCHINDLER ENDOSKOPIE TECHNOLOGIE